DK1940353T3 - Fotostabil farmaceutisk sammensætning indeholdende brivudin til behandling af herpetisk keratitis - Google Patents
Fotostabil farmaceutisk sammensætning indeholdende brivudin til behandling af herpetisk keratitisInfo
- Publication number
- DK1940353T3 DK1940353T3 DK06805904.7T DK06805904T DK1940353T3 DK 1940353 T3 DK1940353 T3 DK 1940353T3 DK 06805904 T DK06805904 T DK 06805904T DK 1940353 T3 DK1940353 T3 DK 1940353T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- pharmaceutical composition
- composition containing
- herpetic keratitis
- containing brivudine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005046769A DE102005046769A1 (de) | 2005-09-29 | 2005-09-29 | Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus) |
| PCT/EP2006/009383 WO2007039201A2 (en) | 2005-09-29 | 2006-09-27 | Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1940353T3 true DK1940353T3 (da) | 2011-01-24 |
Family
ID=37561306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06805904.7T DK1940353T3 (da) | 2005-09-29 | 2006-09-27 | Fotostabil farmaceutisk sammensætning indeholdende brivudin til behandling af herpetisk keratitis |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20080249061A1 (da) |
| EP (1) | EP1940353B1 (da) |
| JP (1) | JP2009509993A (da) |
| KR (1) | KR20080053319A (da) |
| CN (1) | CN101272765A (da) |
| AP (1) | AP2008004394A0 (da) |
| AR (1) | AR056551A1 (da) |
| AT (1) | ATE489076T1 (da) |
| AU (1) | AU2006299115A1 (da) |
| BR (1) | BRPI0616449A2 (da) |
| CA (1) | CA2624111A1 (da) |
| CR (1) | CR9839A (da) |
| CY (1) | CY1111059T1 (da) |
| DE (2) | DE102005046769A1 (da) |
| DK (1) | DK1940353T3 (da) |
| EA (1) | EA012975B1 (da) |
| EC (1) | ECSP088310A (da) |
| ES (1) | ES2356774T3 (da) |
| HN (1) | HN2008000497A (da) |
| HR (1) | HRP20110085T1 (da) |
| IL (1) | IL190466A0 (da) |
| MA (1) | MA29887B1 (da) |
| NO (1) | NO20081488L (da) |
| PE (1) | PE20070767A1 (da) |
| PL (1) | PL1940353T3 (da) |
| PT (1) | PT1940353E (da) |
| RS (1) | RS51615B (da) |
| SI (1) | SI1940353T1 (da) |
| TN (1) | TNSN08094A1 (da) |
| TW (1) | TW200744664A (da) |
| UA (1) | UA90911C2 (da) |
| WO (1) | WO2007039201A2 (da) |
| ZA (1) | ZA200802729B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009006130A2 (en) * | 2007-06-28 | 2009-01-08 | Bausch & Lomb Incorporated | Salt free hyaluronate ophthalmic solution |
| US20090196833A1 (en) * | 2008-02-06 | 2009-08-06 | Adherex Technologies Inc. | Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome |
| DE102009003942A1 (de) * | 2009-01-07 | 2010-07-08 | D2O Biosience Group Ltd., Hamilton | Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges |
| EP2898888B8 (en) | 2014-01-22 | 2019-06-12 | VISUfarma B.V. | Composition comprising iota-carrageenan against viral Conjunctivitis |
| WO2017192944A1 (en) * | 2016-05-06 | 2017-11-09 | SaCSh Corp. | Ophthalmic compositions |
| CN113712928A (zh) * | 2021-09-29 | 2021-11-30 | 重庆市力扬医药开发有限公司 | 经口腔粘膜吸收的溴夫定药物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY136633A (en) * | 2001-01-17 | 2008-11-28 | Berlin Chemie Ag | Stabilized brivudine topical formulations |
| DE10162593A1 (de) * | 2001-12-19 | 2003-07-03 | Menarini Ricerche Spa | Stabilisierte topische Brivudin-Formulierungen |
-
2005
- 2005-09-29 DE DE102005046769A patent/DE102005046769A1/de not_active Withdrawn
-
2006
- 2006-09-27 DK DK06805904.7T patent/DK1940353T3/da active
- 2006-09-27 CA CA002624111A patent/CA2624111A1/en not_active Abandoned
- 2006-09-27 ZA ZA200802729A patent/ZA200802729B/xx unknown
- 2006-09-27 SI SI200630913T patent/SI1940353T1/sl unknown
- 2006-09-27 AT AT06805904T patent/ATE489076T1/de active
- 2006-09-27 EP EP06805904A patent/EP1940353B1/en active Active
- 2006-09-27 CN CNA2006800356965A patent/CN101272765A/zh active Pending
- 2006-09-27 EA EA200800646A patent/EA012975B1/ru not_active IP Right Cessation
- 2006-09-27 KR KR1020087007483A patent/KR20080053319A/ko not_active Withdrawn
- 2006-09-27 ES ES06805904T patent/ES2356774T3/es active Active
- 2006-09-27 US US12/088,397 patent/US20080249061A1/en not_active Abandoned
- 2006-09-27 UA UAA200802782A patent/UA90911C2/ru unknown
- 2006-09-27 AU AU2006299115A patent/AU2006299115A1/en not_active Abandoned
- 2006-09-27 RS RS20110016A patent/RS51615B/en unknown
- 2006-09-27 PL PL06805904T patent/PL1940353T3/pl unknown
- 2006-09-27 AP AP2008004394A patent/AP2008004394A0/xx unknown
- 2006-09-27 BR BRPI0616449-8A patent/BRPI0616449A2/pt not_active IP Right Cessation
- 2006-09-27 PT PT06805904T patent/PT1940353E/pt unknown
- 2006-09-27 DE DE602006018505T patent/DE602006018505D1/de active Active
- 2006-09-27 JP JP2008532659A patent/JP2009509993A/ja not_active Withdrawn
- 2006-09-27 TW TW095135667A patent/TW200744664A/zh unknown
- 2006-09-27 WO PCT/EP2006/009383 patent/WO2007039201A2/en active Application Filing
- 2006-09-28 PE PE2006001181A patent/PE20070767A1/es not_active Application Discontinuation
- 2006-09-28 AR ARP060104294A patent/AR056551A1/es unknown
-
2008
- 2008-02-28 TN TNP2008000094A patent/TNSN08094A1/en unknown
- 2008-03-25 EC EC2008008310A patent/ECSP088310A/es unknown
- 2008-03-26 NO NO20081488A patent/NO20081488L/no not_active Application Discontinuation
- 2008-03-27 CR CR9839A patent/CR9839A/es not_active Application Discontinuation
- 2008-03-27 HN HN2008000497A patent/HN2008000497A/es unknown
- 2008-03-27 IL IL190466A patent/IL190466A0/en unknown
- 2008-04-24 MA MA30877A patent/MA29887B1/fr unknown
-
2010
- 2010-12-23 CY CY20101101189T patent/CY1111059T1/el unknown
-
2011
- 2011-02-03 HR HR20110085T patent/HRP20110085T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1868579T3 (da) | Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| DK2046767T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
| DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
| CY2017007I2 (el) | Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK3567035T3 (da) | N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer | |
| DK2292607T3 (da) | Fremgangsmåde til syntese af organiske forbindelser | |
| DK2044028T3 (da) | Cyanoisoquinolinforbindelser til stabilisering af den hypoxiinducerende faktor (HIF) | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DE112006004277A5 (de) | Glaszusammensetzung | |
| DK2178863T3 (da) | Fremgangsmåde til syntetisering af anvendelige forbindelser til behandling af hepatitis C | |
| DK1945271T3 (da) | Fremgangsmåde til fremstilling af polymerbelagte mikropartikler | |
| RU2398586C3 (ru) | Фармацевтическая композиция | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| EP1967540A4 (en) | HARDENING COMPOSITION | |
| FR2883877B1 (fr) | Procede de preparation de compositions de diester(s) de dianhydrohexitol | |
| NO20076030L (no) | Fremgangsmåte for fremstilling av hydroklorsilaner | |
| DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
| DE602007002320D1 (de) | Antibeschlagbeschichtungszusammensetzung | |
| DE602006010127D1 (de) | Härtbare Zusammensetzung | |
| DK1686160T3 (da) | Forbedret coatingsammensætning | |
| DK1940353T3 (da) | Fotostabil farmaceutisk sammensætning indeholdende brivudin til behandling af herpetisk keratitis | |
| DK1856035T3 (da) | Fremgangsmåde til fremstilling af beskyttelse amidiner | |
| DK1912961T3 (da) | Fremgangsmåde til fremstilling af bepromolin |